Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Oral Cavity Cancer in a Rural Midwest United States Population
Mayo Clinic
Mayo Clinic
University of Washington
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Michigan Rogel Cancer Center
Mayo Clinic
Fred Hutchinson Cancer Center
Ohio State University Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Wake Forest University Health Sciences
Fred Hutchinson Cancer Center
Roswell Park Cancer Institute
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Emory University
M.D. Anderson Cancer Center
Mayo Clinic
St. Jude Children's Research Hospital
Mayo Clinic
Mayo Clinic
Mayo Clinic
Ohio State University Comprehensive Cancer Center
Roswell Park Cancer Institute
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
Wake Forest University Health Sciences
Wake Forest University Health Sciences